Clinical Trial: Control of Therapy of Acne Papulopustulosa by Visible Light With Waterfiltered Infrared and / or Adapalen (Differin Gel)

This study is not yet open for patient recruitment.
Verified by Dresden University of Technology October 2005

Sponsored by: Dresden University of Technology
Information provided by: Dresden University of Technology
ClinicalTrials.gov Identifier: NCT00237978

Purpose

The aim of the study is to investigate the effectivity of visible light in combination with waterfiltered infrared in treating acne papulopustulosa. The reduction of inflammatory and non-inflammatory lesions within 8 weeks will be measured and compared with the standard treatment with Adapalene.
Condition Intervention Phase
Acne Papulopustulosa
 Drug: Differin Gel
Phase IV

MedlinePlus consumer health information 

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study

Eligibility

Ages Eligible for Study:  14 Years and above,  Genders Eligible for Study:  Both
Criteria

Inclusion Criteria:

  • Mild to moderate acne papulopustulosa according to Burton Scale Stage 3 to 4
  • At least 5 inflammatory and 5 non-inflammatory lesions in the face
  • Age >= 14 years

Exclusion Criteria:

  • pregnant and nursing women
  • Antiandrogen therapy
  • therapy with antibiotics within the last 4 weeks
  • therapy with retinoids within the last 6 months
  • natural or artificial UV-therapy within the last 4 weeks
  • severe acne papulopustulosa according to Burton Scale 5 or 6
  • Severe systemic condition
  • Secondary acne

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00237978

Roland Aschoff, MD      0049-351-458  Ext. 2007    Roland.Aschoff@mailbox.tu-dresden.de

Germany, Sachsen
      Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden,  Sachsen,  01307,  Germany
Roland Aschoff, MD  0049-351-458  Ext. 2007    Roland.Aschoff@mailbox.tu-dresden.de 

Study chairs or principal investigators

Roland Aschoff, MD,  Principal Investigator,  Technische Universität Dresden, Fetscher Str. 74, 01307 Dresden, Germany   

More Information

Study ID Numbers:  Akne02
Last Updated:  December 8, 2005
Record first received:  October 12, 2005
ClinicalTrials.gov Identifier:  NCT00237978
Health Authority: Germany: Federal Institute for Drugs and Medicinal Devices
ClinicalTrials.gov processed this record on 2006-01-10

Resources




Common Treatments

[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Follow Us